Kenneth Attie - SVP, CMO at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp, Cmo
Stock Symbol
ELVN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kenneth Attie since 8/15/2023

Holdings reported by Kenneth Attie for Enliven Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 34.1K $516K $15.14 Jan 28, 2022 Direct
Stock Option (right to buy) 34.1K Jan 28, 2022 Direct Common Stock

Transactions reported by Kenneth Attie for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership